Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'r pfi 2 hydrochloride'

Search results for: 'r pfi 2 hydrochloride'

Items 1-10 of 122

Page
per page
  1. (R)-PFI 2 hydrochloride
    B8210 (R)-PFI 2 hydrochloride
      ≥26.8 mg/mL
  2. (S)-PFI-2 (hydrochloride)
    C4834 (S)-PFI-2 (hydrochloride)
    Summary: Negative control of (R)-PFI 2 hydrochloride
      ≤0.5 mg/mL
  3. PFI-2
    B4875 PFI-2
     1 Citation
    Target: SETD7
    Summary: SETD7 methyltransferase inhibitor
      ≥50 mg/mL
  4. PFI-1 (PF-6405761)
    A4184 PFI-1 (PF-6405761)
     1 Citation
    Target: Bromodomains
    Summary: BET inhibitor
      insoluble in H2O; insoluble in EtOH; ≥128.4 mg/mL
  5. PFI 4
    B5973 PFI 4
    Summary: Potent and selective BRPF1 Bromodomain inhibitor
      insoluble in H2O; ≥13.3 mg/mL
  6. PFI 3
    B7744 PFI 3
    Target: Protein polybromo-1|SMARCA4|SMARCA2
    Summary: inhibitor of polybromo 1 and SMARCA4
      insoluble in H2O; ≥15.15 mg/mL
  7. 2-Methoxyestradiol (2-MeOE2)
    A4188 2-Methoxyestradiol (2-MeOE2)
     2 Citation
    Summary: Apoptotic, antiproliferative and antiangiogenic agent
      insoluble in H2O; ≥15.25 mg/mL
  8. PJ34 hydrochloride
    A4159 PJ34 hydrochloride
    Summary: PARP inhibitor,potent and cell-permeable
      insoluble in H2O; insoluble in EtOH; ≥16.6 mg/mL
  9. Resminostat hydrochloride
    A3755 Resminostat hydrochloride
    Summary: HDAC inhibitor
      Soluble in DMSO
  10. 3-Deazaneplanocin A (DZNep) hydrochloride
    A8182 3-Deazaneplanocin A (DZNep) hydrochloride
     1 Citation
    Target: EZH2
    Summary: SAHH and EZH2 inhibitor
      insoluble in EtOH; ≥14.94 mg/mL

Items 1-10 of 122

Page
per page
Shop By
Now Shopping by
  1. Category Chromatin/Epigenetics Remove This Item
Clear All
Shopping Options
Category
  1. Bromodomain 10item
  2. Aurora Kinase 6item
  3. DNA Methyltransferase 4item
  4. HDAC 17item
  5. Histone Acetyltransferases 6item
  6. Histone Demethylases 3item
  7. Histone Methyltransferase 18item
  8. HIF 4item
  9. JAK 15item
  10. MBT Domains 1 item
  11. PARP 17item
  12. Pim 4item
  13. Protein Ser/Thr Phosphatases 10item
  14. Sirtuin 3item
  15. Sphingosine Kinase-2 1 item
  16. Polycomb repressive complex 1 item
  17. SUMOylation 2item
Specificity
  1. Selective 42item
Reversibility
  1. Reversible 3item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 11item
  3. PI3K 1 item
  4. Aurora Kinases 4item
  5. EZH2 3item
  6. Bromodomains 4item
  7. FLT3 1 item
  8. DOT1L 1 item
  9. Pim 1 item
  10. Sir2-like Family Deacetylases (Sirtuins) 1 item
  11. STAT 1 item
  12. JAK 9item
  13. EZH1 1 item
  14. TNKS 1 item
  15. DNA Methyltransferases 2item
  16. SMYD2 1 item
  17. PARP 5item
  18. phosphatases 1 item
  19. G9a 1 item
  20. SETD7 1 item
  21. MNK 1 item
  22. AChE 1 item
  23. Cytidine deaminases 1 item
  24. c-RET 1 item
  25. Protein polybromo-1 1 item
  26. SMARCA4 1 item
  27. SMARCA2 1 item
  28. HDAC 1 item
  29. KDM 1 item
  30. Histone Acetyltransferases (HATs) 1 item
  31. PHF 1 item
  32. SK 1 item
Reported Experiments
  1. Animal Experiments 43item
  2. Cell Experiments 36item
Related Disease
  1. Acute Myeloid Leukemia 3item
  2. Bladder Cancer 1 item
  3. Bladder Carcinoma 1 item
  4. Breast Cancer 7item
  5. Cancer 30item
  6. Cervical Cancer 2item
  7. Colon Cancer 3item
  8. Colon Carcinoma 1 item
  9. Colorectal Cancer 1 item
  10. Diabetes 1 item
  11. Glioma 2item
  12. Hepatocellular Carcinoma 1 item
  13. HIV 2item
  14. HIV Infections 1 item
  15. Immunological Diseases 1 item
  16. Inflammatory Bowel Disease 1 item
  17. Inflammatory Diseases 2item
  18. Leukemia 4item
  19. Lung Cancer 3item
  20. Lymphoma 1 item
  21. Melanoma 1 item
  22. Mixed Lineage Leukemia 1 item
  23. Multiple Myeloma 2item
  24. Myelofibrosis 1 item
  25. Myeloma 1 item
  26. Non-small Cell Lung Cancer 2item
  27. Ovarian Cancer 1 item
  28. Pancreatic Cancer 2item
  29. Prostate Cancer 5item
  30. Psoriasis 1 item
  31. Renal Cell Carcinoma 1 item
  32. Rheumatoid Arthritis 2item
  33. Type 2 Diabetes 1 item